Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.43M Buy
94,960
+48,797
+106% +$2.26M 0.03% 430
2026
Q1
$2.26M Buy
46,163
+19,152
+71% +$891K 0.02% 588
2025
Q4
$1.18M Sell
27,011
-14,013
-34% -$640K 0.01% 737
2025
Q3
$1.85M Sell
41,024
-25,658
-38% -$1.13M 0.02% 603
2025
Q2
$2.9M Buy
66,682
+13,018
+24% +$580K 0.03% 404
2025
Q1
$2.47M Buy
53,664
+16,754
+45% +$700K 0.04% 406
2024
Q4
$1.39M Buy
36,910
+20,322
+123% +$788K 0.02% 530
2024
Q3
$673K Sell
16,588
-2,905
-15% -$109K 0.02% 789
2024
Q2
$675K Buy
19,493
+3,008
+18% +$111K 0.02% 747
2024
Q1
$619K Sell
16,485
-58,175
-78% -$2.08M 0.01% 735
2023
Q4
$2.68M Buy
74,660
+24,252
+48% +$934K 0.07% 307
2023
Q3
$1.9M Buy
+50,408
New +$2.05M 0.06% 321

Other funds holding EXC

Vident Advisory's EXC Position: Q2 2026 in Review

Vident Advisory increased its Exelon (EXC) stake by 106% in Q2 2026, buying an estimated $2.26M and bringing the position to 94,960 shares worth $4.43M. The position accounts for 0.03% of the portfolio, ranked #430.

Vident Advisory first reported a position in EXC in Q3 2023 and has held it in 12 quarters since. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Vident Advisory held 94,960 shares of Exelon worth $4.43M as of Q2 2026.
  • Vident Advisory bought 48,797 Exelon shares in Q2 2026, an estimated $2.26M.
  • Exelon made up 0.03% of Vident Advisory's portfolio in Q2 2026, its #430 holding.
  • Vident Advisory first reported a position in Exelon in Q3 2023 and has held it in 12 quarters since.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.